Market Overview

Suntrust Initiates Coverage on Catalyst Pharmaceutical at Buy, Announces $7.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CPRX

DateFirmActionFromTo
Oct 2016PiperJaffrayUpgradesNeutralOverweight
Apr 2016PiperJaffrayDowngradesOverweightNeutral
Jun 2015MLV & Co.Initiates Coverage onBuy

View More Analyst Ratings for CPRX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (CPRX)